Gary J. Faerber
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Gary J. Faerber has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
- David A. Bloom
Univ Michigan, Sch Med, Dept Urol, Ann Arbor, MI USA
1 shared publication - Jr. J. Stuart Wolf
Department of Urology, University of Michigan , Ann Arbor, Michigan
1 shared publication - Ryan Swearingen
Department of Urology, University of Michigan , Ann Arbor, Michigan
1 shared publication - Sapan Nitin Ambani
Department of Urology, University of Michigan Health System, Ann Arbor, MI
1 shared publication
Latest Publications
- 1 May 2016
- Published by SAGE Publications in Journal of Endourology
- Vol. 30 (S1) , S23-23
Definitive Management of Failure After Pyeloplasty
Introduction: Failure after pyeloplasty is difficult to manage. We report our experience managing pyeloplasty failures. Methods: We retrospectively reviewed the case log of a single surgeon, from August 1996 to August 2014 to identify all patients undergoing a surgical procedure after failed pyeloplasty. We excluded patients without follow up exceeding 1 year from initial post-pyeloplasty procedure. Failure was defined as need for additional definitive intervention. Results: Of 247 laparoscopic pyeloplasties, 68 endopyelotomies and 305 simple laparoscopic nephrectomies reviewed, 41 were performed after previous pyeloplasty and had sufficient follow up. Laparoscopic nephrectomy was performed in 9 patients. All 3 secondary laparoscopic pyeloplasties were successful. Of 29 secondary endopyelotomies, 10 (34%) were successful. Of the 19 failures after secondary endopyelotomy, 12 patients had tertiary pyeloplasty (5 laparoscopic and 7 open surgical), 5 (26%) underwent tertiary endopyelotomy, and 2 (11%) required nephrectomy. Our overall endopyelotomy success rate was 38% (13/34), versus 100% (11/11) for secondary or tertiary pyeloplasty (4 patients lost to follow up). Median time to failure was 5 months for endopyelotomy. Median follow up for patients free from intervention was 40.2 months. Conclusions: Secondary pyeloplasty (including both laparoscopic and open surgical approach) is more than twice as successful as endopyelotomy after failed pyeloplasty. Secondary pyeloplasty is an excellent alternative to endopyelotomy in select patients with failure after initial pyeloplasty.
- 1 May 2016
- Published by SAGE Publications in Journal of Endourology
- Vol. 30 (S1) , S23-23
Definitive Management of Failure After Pyeloplasty
Introduction: Failure after pyeloplasty is difficult to manage. We report our experience managing pyeloplasty failures. Methods: We retrospectively reviewed the case log of a single surgeon, from August 1996 to August 2014 to identify all patients undergoing a surgical procedure after failed pyeloplasty. We excluded patients without follow up exceeding 1 year from initial post-pyeloplasty procedure. Failure was defined as need for additional definitive intervention. Results: Of 247 laparoscopic pyeloplasties, 68 endopyelotomies and 305 simple laparoscopic nephrectomies reviewed, 41 were performed after previous pyeloplasty and had sufficient follow up. Laparoscopic nephrectomy was performed in 9 patients. All 3 secondary laparoscopic pyeloplasties were successful. Of 29 secondary endopyelotomies, 10 (34%) were successful. Of the 19 failures after secondary endopyelotomy, 12 patients had tertiary pyeloplasty (5 laparoscopic and 7 open surgical), 5 (26%) underwent tertiary endopyelotomy, and 2 (11%) required nephrectomy. Our overall endopyelotomy success rate was 38% (13/34), versus 100% (11/11) for secondary or tertiary pyeloplasty (4 patients lost to follow up). Median time to failure was 5 months for endopyelotomy. Median follow up for patients free from intervention was 40.2 months. Conclusions: Secondary pyeloplasty (including both laparoscopic and open surgical approach) is more than twice as successful as endopyelotomy after failed pyeloplasty. Secondary pyeloplasty is an excellent alternative to endopyelotomy in select patients with failure after initial pyeloplasty.